Literature DB >> 26153870

Characterization of microRNA expression profiling in peripheral blood lymphocytes in rats with experimental autoimmune uveitis.

Dadong Guo1, Jiao Li, Zhengfeng Liu, Kai Tang, Huixin Song, Hongsheng Bi.   

Abstract

OBJECTIVE AND
DESIGN: We aimed to investigate the alterations of microRNA (miRNA) genomics in peripheral blood lymphocytes in experimental autoimmune uveitis (EAU) rats versus control samples. MATERIALS/
METHODS: Six Lewis rats received interphotoreceptor retinoid-binding protein (IRBP) emulsion to induce EAU. On day 12, peripheral blood lymphocytes were isolated, and total RNAs were extracted. Using microarray analysis, we analyzed the aberrant miRNAs, validated the relevant expression of differentially expressed miRNAs, and predicted the possible miRNA targets and signaling pathways.
RESULTS: The results indicated that 36 miRNAs were upregulated and 31 miRNAs were downregulated in EAU rats versus normal samples. Real-time quantitative PCR substantiated a high degree of confidence for the differentially expressed miRNAs, and miRNA analyses showed the differentially expressed miRNA targets were involved not only in the multicellular organismal process and developmental process, but also in T cell receptor signaling pathway, B cell receptor signaling pathway and so on.
CONCLUSIONS: Our findings show that the differentially expressed miRNAs in EAU rats were closely associated with immune signaling pathways and may be applied in early prevention, prognosis and possible therapy in uveitis, indicating that miRNAs play an important role in the development of uveitis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26153870     DOI: 10.1007/s00011-015-0848-3

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  49 in total

Review 1.  The natural history of uveitis.

Authors:  R B Nussenblatt
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

2.  Endotoxin-induced uveitis. Kinetics and phenotype of the inflammatory cell infiltrate and the response of the resident tissue macrophages and dendritic cells in the iris and ciliary body.

Authors:  P G McMenamin; J Crewe
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-09       Impact factor: 4.799

Review 3.  TLRs as miRNA receptors.

Authors:  Muller Fabbri
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

4.  Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis.

Authors:  Takeru Yoshimura; Koh-Hei Sonoda; Yoshiyuki Miyazaki; Yoichiro Iwakura; Tatsuro Ishibashi; Akihiko Yoshimura; Hiroki Yoshida
Journal:  Int Immunol       Date:  2007-12-21       Impact factor: 4.823

5.  TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

Authors:  Ahjoku Amadi-Obi; Cheng-Rong Yu; Xuebin Liu; Rashid M Mahdi; Grace Levy Clarke; Robert B Nussenblatt; Igal Gery; Yun Sang Lee; Charles E Egwuagu
Journal:  Nat Med       Date:  2007-05-13       Impact factor: 53.440

6.  Protein kinase Czeta (PKCzeta) regulates ocular inflammation and apoptosis in endotoxin-induced uveitis (EIU): signaling molecules involved in EIU resolution by PKCzeta inhibitor and interleukin-13.

Authors:  Yvonne de Kozak; Boubaker Omri; Justine R Smith; Marie-Christine Naud; Brigitte Thillaye-Goldenberg; Patricia Crisanti
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

7.  Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype.

Authors:  Jun Tang; Wei Zhu; Phyllis B Silver; Shao-Bo Su; Chi-Chao Chan; Rachel R Caspi
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

8.  A newly identified microRNA, mmu-miR-7578, functions as a negative regulator on inflammatory cytokines tumor necrosis factor-α and interleukin-6 via targeting Egr1 in vivo.

Authors:  Jinsong Zhang; Shengsong Xie; Wubin Ma; Yu Teng; Ye Tian; Xingxu Huang; Yonglian Zhang
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

9.  Upregulated IL-21 and IL-21 receptor expression is involved in experimental autoimmune uveitis (EAU).

Authors:  Lan Liu; Yongfeng Xu; Jianyong Wang; Huiyan Li
Journal:  Mol Vis       Date:  2009-12-31       Impact factor: 2.367

10.  The effect of toll-like receptor 4 on macrophage cytokines during endotoxin induced uveitis.

Authors:  Shuo Yang; Hong Lu; Jing Wang; Xin Qi; Xuhui Liu; Xiaolong Zhang
Journal:  Int J Mol Sci       Date:  2012-06-18       Impact factor: 6.208

View more
  5 in total

1.  Regulatory Role of rno-miR-30b-5p in IL-10 and Toll-like Receptor 4 Expressions of T Lymphocytes in Experimental Autoimmune Uveitis In Vitro.

Authors:  Yuanyuan Sun; Dadong Guo; Bin Liu; Xuewei Yin; Huixia Wei; Kai Tang; Hongsheng Bi
Journal:  Mediators Inflamm       Date:  2018-10-29       Impact factor: 4.711

2.  MicroRNA expression profile of Lacrimal Glands in rabbit autoimmune dacryoadenitis model.

Authors:  Bo Liu; Lu Zhao; Yankai Wei; Sisi Chen; Lingzhai Bian; Di Guo; Min Gao; Hong Nian
Journal:  Int J Med Sci       Date:  2020-10-16       Impact factor: 3.738

3.  Analyses of circRNA and mRNA Profiles in Vogt-Koyanagi-Harada Disease.

Authors:  Jia Shu; Guannan Su; Jun Zhang; Zhangluxi Liu; Rui Chang; Qingfeng Wang; Peizeng Yang
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

4.  Integrative analysis of genome-wide association studies and gene expression analysis identifies pathways associated with rheumatoid arthritis.

Authors:  Mingming Zhang; Hongbo Mu; Hongchao Lv; Lian Duan; Zhenwei Shang; Jin Li; Yongshuai Jiang; Ruijie Zhang
Journal:  Oncotarget       Date:  2016-02-23

5.  Regulatory roles of differentially expressed MicroRNAs in metabolic processes in negative Lens-induced myopia Guinea pigs.

Authors:  Dadong Guo; Meihua Ding; Xiaoli Song; Yuanyuan Sun; Guoping Li; Zonghong Li; Huixia Wei; Jianfeng Wu; Wenjun Jiang; Hongsheng Bi
Journal:  BMC Genomics       Date:  2020-01-06       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.